|
0
|
|
A comprehensive functional atlas of ALK kinase domain variants reveals resistance landscape to ALK inhibitors.
(link.springer.com)
|
Oh HC
…
Kim HH
Genome Biology
2026-02-03
|
#amr
#cancer
#mutagenesis
#kinase
#variant
|
|
0
|
|
Transcriptomic landscape of transposable elements reveals LTR7-PLAAT4 as a potential oncogene and therapeutic target in pancreatic adenocarcinoma.
(genome.cshlp.org)
|
Shi M
…
Li J
Genome Research
2026-02-03
|
#transcriptomics
#cancer
#immunotherapy
#oncogene
#neoantigens
|
|
0
|
|
Fe metal-organic framework-derived heterojunction for metabolic diagnosis of thymic epithelial tumor.
(pnas.org)
|
Liang Y
…
Chen XM
PNAS
2026-02-03
|
#metabolomics
#cancer
#diagnosis
#biomarker
|
|
0
|
|
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types.
(pnas.org)
|
Ahmad S
…
Das J
PNAS
2026-02-03
|
#modeling
#immunity
#cancer
#immunotherapy
#cytotoxicity
|
|
0
|
|
X-intNMF: a cross- and intra-omics regularized NMF framework for multi-omics integration.
(academic.oup.com)
|
Bui TT
…
Zhang W
Bioinformatics
2026-02-03
|
#modeling
#transcriptomics
#cancer
#multi-omics
#integration
|
|
0
|
|
Intronic polyadenylation-derived long noncoding RNA modulates nucleolar integrity and function.
(pnas.org)
|
Mallick S
…
Singh I
PNAS
2026-02-03
|
#transcriptomics
#cancer
#ncrna
#nucleolus
#rrna processing
|
|
0
|
|
Integrated mutational landscape analysis of endometrial stromal sarcoma.
(pnas.org)
|
Hartwich TMP
…
Santin AD
PNAS
2026-02-03
|
#transcriptomics
#cancer
#sequencing
#mutation
#oncology
|
|
0
|
|
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.
(link.springer.com)
|
Paoli M
…
Benelli M
Genome Medicine
2026-02-03
|
#modeling
#methylation
#cancer
#sequencing
#biomarker
|
|
0
|
|
Inhibitory probes for spatiotemporal analysis of Galpha(s) protein signaling.
(nature.com)
|
Zhao J
…
Garcia-Marcos M
Nature Chemical Biology
2026-02-03
|
#cancer
#signaling
#gpcr
#probes
|
|
0
|
|
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.
(pnas.org)
|
Traphagen NA
…
Brown M
PNAS
2026-02-03
|
#amr
#cancer
#dna repair
#prostate
#homologous recombination
|
|
0
|
|
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.
(elifesciences.org)
|
Zhang Y
…
Hu X
eLife
2026-02-03
|
#immunity
#cancer
#epigenetics
#drug combination
#dna repair
|